Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Wertheim cung cấp cho các bạn kiến thức về ngành y đề tài: Outcome of open and endovascular repair in acute type B aortic dissection: a retrospective and observational study. | Mastroroberto et al. Journal of Cardiothoracic Surgery 2010 5 23 http content 5 1 23 JOTS JOURNAL OF CARDIOTHORACIC SURGERY RESEARCH ARTICLE Open Access Outcome of open and endovascular repair in acute type B aortic dissection a retrospective and observational study 1 I- Z- . l 7i 1 1 2 Pasquale Mastroroberto Francesco Onorati Saverio Zofrea Attilio Renzulli Ciro Indolfi Abstract Background The aim of the study was to analyze surgical and endovascular results in the treatment of acute type B aortic dissection B AAD . Methods Retrospective and observational analysis with patient inclusion between January 2001-December 2008 and follow-up ranged from 2 to 96 months median was performed. Out of 51 consecutive patients with B AAD 11 had to undergo open surgery OS and 13 endovascular treatment TEVAR . Results There was a significantly difference in early mortality in the TEVAR group 0 13 0 vs OS group 4 11 P and in the incidence of paraplegia paraparesis OS 2 vs TEVAR 1 P renal failure OS 3 vs TEVAR 1 P respiratory failure OS 2 vs TEVAR 1 P and cerebrovascular accident OS 1 vs TEVAR 0 0 P . The late mortality at a follow-up was 4 13 in the TEVAR group and 3 7 in the OS group respectively P not significant . The cumulative survival rate after 1 3 and 8 years was 93 84 and 69 in the TEVAR group and 86 71 and 57 in the OS group respectively. Endoleaks were diagnosed in 2 13 endovascular patients . Conclusions TEVAR group had a significantly reduction in early mortality and postoperative complications. No significant differences were found in terms of cumulative survival at follow-up. On this basis TEVAR could be considered an option in the treatment of these complex cases with all proper reservation especially related to the small sample sizes examined. Background The treatment of Stanford type B acute aortic dissection B AAD still remains a formidable .
